{"success":true,"data":{"pressRelease":{"id":"51093","rtpr_id":"nBw9Txwkpa","ticker":"ALMDT","exchange":"Euronext Paris","all_tickers":["ALMDT"],"title":"Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutional Investors","author":"Business Wire","published_at":"2026-06-01T15:45:00.087Z","article_body":"Median Technologies Brings Forward Subscription Period of its €50 Million\nCapital Increase on the Back of Strong Demand from Institutional Investors\n\n\n * The €50 million capital increase, with a subscription price of €5.00 per\nNew Share launched on May 27, 2026, is already oversubscribed\n\n * The Public Offering period, initially scheduled to close on June 3, 2026, will\nnow close early on June 2, 2026, at 5:00 p.m. (Paris time) for subscriptions\nmade over-the-counter and at 8:00 p.m. (Paris time) for online subscriptions\n\n * The Global Placement offering period closing is also brought forward to June\n2, 2026 at 5:00 p.m. (Paris time)\n\nNot to be published, distributed or disseminated, directly or indirectly, in\nthe United States of America, Australia, Canada, South Africa and Japan\n\nRegulatory News:\n\nMedian Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible,\n“Median” or the “Company”), developer of eyonis®, a suite of\nartificial intelligence (AI) powered Software as a Medical Device (SaMD) for\nearly cancer diagnosis, and a leading provider of AI-based image analyses and\ncentral imaging services for oncology clinical trials in the biopharmaceutical\nindustry, today announces the early closing of its capital increase without\nshareholders’ preferential subscription rights by way of an issue of new\nordinary shares (the “New Shares”) in the context of a public offering.\nThe New Shares are offered in (i) a public offering in France (the “Public\nOffering”), and a global placement to certain qualified investors (the\n“Global Placement”, together with the Public Offering, the “Global\nOffering”) for an amount of €40 million and (ii) an offering reserved to\nKatarina Martinson AB, Venture S.a.r.l, and Nordica Life (Bermuda) Ltd for an\namount of €10 million (the “Reserved Offering” and, together with the\nGlobal Offering, the “Offering”).\n\nOn the strength of the level of oversubscription recorded, Median Technologies\nhas decided to close the Public Offering period early on June 2, 2026, at 5:00\np.m. (Paris time) for subscriptions made over-the-counter and at 8:00 p.m.\n(Paris time) for online subscriptions. The Global Placement offering period\nwill close on June 2, 2026, at 5:00 p.m. (Paris time).\n\nFor reference, the Public Offering was initially scheduled to close on June 3,\n2026, at the same times, and the Global Placement on June 4, 2026, at 12:00\np.m. (Paris time).\n\nSettlement and delivery will also be brought forward to June 5, 2026, instead\nof the initially contemplated June 9, 2026.\n\nThe timetable of the Offering is therefore amended as follows:\n May 26, 2026  Decision of the Company’s Board of Directors and the Chief Executive Officer    \n               to launch the capital increase and set the issue price                          \n May 27, 2026  Publication of the press release announcing the launch of the Public Offering   \n               and the Global Placement – Online availability of the information document      \n               \n                                                                               \n               \nPublication by Euronext of the notice of opening of the Public Offering        \n June 2, 2026  Closing of the Global Placement offering period at 5:00 p.m. (Paris time)       \n               \n                                                                               \n               \nClosing of the Public Offering period at 5:00 p.m. (Paris time) for            \n               over-the-counter subscription orders and at 8:00 p.m. (Paris time) for          \n               subscription orders made via the Internet (if such possibility is offered by    \n               the relevant financial intermediary)                                            \n June 3, 2026  Centralization                                                                  \n               \n                                                                               \n               \nDetermination of the final terms of the capital increase (including the        \n               Reserved Offering amount)                                                       \n               \n                                                                               \n               \nSigning of the placement agreement                                             \n               \n                                                                               \n               \nPublication by the Company of the press release announcing the results of the  \n               capital increase after market close                                             \n               \n                                                                               \n               \nPublication by Euronext of the notice of results of the Offering               \n June 5, 2026  Issuance and admission to trading of the New Shares on Euronext Growth          \n               \n                                                                               \n               \nSettlement and delivery of the New Shares                                      \n\n\nAll information relating to the Offering is available on the Company’s\nwebsite at www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=1&md5=8d150a5d40d4aae7075ab26a09e4448b)\n.\n\nAbout Median Technologies: Pioneering innovative software as a medical device\nand imaging services, Median Technologies harnesses cutting-edge AI to enhance\nthe accuracy of early cancer diagnoses and treatments. Median's offerings\ninclude iCRO, which provides medical image analysis and management in oncology\ntrials, and eyonis®, an AI/ML tech-based suite of software as a medical\ndevice (SaMD). Median empowers biopharmaceutical entities and clinicians to\nadvance patient care and expedite the development of novel therapies. The\nFrench-based company, with a presence in the U.S. and China, trades on the\nEuronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also\neligible for the French SME equity savings plan scheme (PEA-PME). For more\ninformation, visit www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=2&md5=58fe4a2cc4ddc339d03dd3235af71a65)\n.\n\nForward‑looking statements\n\nThis press release contains forward‑looking statements. These statements do\nnot constitute historical facts. These statements include projections and\nestimates and the assumptions on which they are based, statements regarding\nplans, objectives, intentions and expectations with respect to future\nfinancial results, events, operations, services, product development and their\npotential, or future performance.\n\nThese forward‑looking statements can often be identified by the use of words\nsuch as “expect”, “anticipate”, “believe”, “intend”,\n“hope”, “estimate”, “forecast,” “project,” “seek,”\n“endeavor”, “aim”, “may”, “goal”, “objective”,\n“projection”, or “plan”, as well as other similar terms. Although the\nmanagement of Median believes that these forward‑looking statements are\nreasonable, investors and shareholders are cautioned that these\nforward‑looking statements are subject to numerous risks and uncertainties,\nwhich are difficult to predict and generally beyond the control of Median\nTechnologies, and which could cause actual results and events to differ\nmaterially from those expressed, implied or forecast in the forward‑looking\ninformation and statements.\n\nThese risks and uncertainties include those described or identified in public\ndocuments, including those listed in section p), “Specific Risk Factors,”\nof the 2025 annual financial report.\n\nAll forward‑looking statements contained in this press release are based on\ninformation available to Median Technologies as of the date of this press\nrelease. Median Technologies undertakes no obligation to update the\nforward‑looking information and statements included in the press release to\nreflect any changes affecting the forecasts or the events, conditions, or\ncircumstances on which such forward-looking statements are based.\n\nAny information relating to past performance contained in this press release\nshould not be considered a guarantee of future performance. Nothing in this\npress release should be considered an investment recommendation or legal, tax,\ninvestment, or accounting advice.\n\nDisclaimer\n\nIn France, the offering of Median Technologies shares described above will be\ncarried out by way of a public offering, mainly intended for natural persons,\nand a global placement intended for qualified investors as defined in Article\n2(e) of Regulation (EU) 2017/1129 of the European Parliament and of the\nCouncil of 14 June 2017, as amended (the “Prospectus Regulation”). It will\nbe supplemented by a reserved offering to investors who have undertaken to\nsubscribe for a fixed amount at the launch of the Public Offering, if the\nsubscriptions received in the context of the Public Offering and the Global\nPlacement do not allow their subscription amount to be fully allocated, in the\ncontext of an issue reserved for a category of persons in accordance with\nArticle L.225-138 of the French Commercial Code.\n\nPursuant to the provisions of Article 211-3 of the General Regulation of the\nAutorité des marchés financiers (the “AMF”), Articles 1(4) and 3 of the\nProspectus Regulation and the applicable regulations, the offering of Median\nTechnologies shares will not give rise to the preparation of a prospectus\napproved by the AMF but only of a document containing the information set out\nin Annex IX of the Prospectus Regulation (the “Information Document”). A\ncopy of the Information Document is available on Median Technologies’\nwebsite (www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=3&md5=ec808c16cca3cff0324960a89533a091)\n).\n\nMedian Technologies draws the attention of the public in France and of\nqualified investors in the permitted jurisdictions to section VIII “Risk\nfactors specific to the Issuer” of the Information Document.\n\nThis press release does not constitute and shall not be considered as\nconstituting a public offer, a solicitation or a sale in any jurisdiction in\nwhich such offer, solicitation or sale would be unlawful prior to registration\nor qualification under the securities laws of such jurisdiction.\n\nWith respect to the member states of the European Economic Area other than\nFrance, no action has been or will be taken to permit a public offer of the\nsecurities referred to in this press release requiring the publication of a\nprospectus in any of these member states. Accordingly, the securities may not\nbe offered and will not be offered in these member states (i) other than to\nqualified investors within the meaning of the Prospectus Regulation or (ii) in\naccordance with the other exemptions provided for in Article 1(4) of the\nProspectus Regulation or in other cases not requiring Median Technologies to\npublish a prospectus pursuant to Article 3 of the Prospectus Regulation and/or\nthe applicable regulations in such member state or in accordance with the\napplicable regulations.\n\nThis press release and the information contained herein are addressed to and\nintended only for persons who are (x) outside the United Kingdom or (y) in the\nUnited Kingdom and (i) who are “qualified investors” (as defined in\nArticle 15 of Schedule 1 to the Public Offers and Admissions to Trading\nRegulations 2024) and investment professionals within the meaning of Article\n19(5) of the Financial Services and Markets Act 2000 (Financial Promotion)\nOrder 2005, as amended (the “Financial Promotion Order”) or (ii) who fall\nwithin Article 49(2)(a) to (d) of the Financial Promotion Order (“high net\nworth companies, unincorporated associations etc.”) or (iii) are persons to\nwhom an invitation or inducement to engage in investment activity (within the\nmeaning of Article 21 of the Financial Services and Markets Act 2000) may\nlawfully be communicated or caused to be communicated (such persons referred\nto in paragraphs (y)(i), (y)(ii) and (y)(iii) together being the “Relevant\nPersons”). Any invitation, offer or agreement to subscribe for or purchase\nthe securities referred to in this press release is only available to Relevant\nPersons and may only be engaged in with Relevant Persons. This press release\nis directed only at Relevant Persons and must not be acted on or relied on by\npersons who are not Relevant Persons.\n\nThis press release may not be distributed, directly or indirectly, in the\nUnited States. This press release and the information contained herein do not\nconstitute an offer to subscribe for or purchase, or the solicitation of an\norder to purchase or subscribe for, Median Technologies shares in the United\nStates or in any other jurisdiction in which such offer or solicitation would\nbe unlawful. Securities may not be offered or sold in the United States absent\nregistration or an exemption from registration under the U.S. Securities Act\nof 1933, as amended (the “U.S. Securities Act”). Median Technologies\nshares have not been and will not be registered under the U.S. Securities Act\nand Median Technologies does not intend to conduct a public offering of Median\nTechnologies shares in the United States.\n\nThe distribution of this press release may be subject to specific regulations\nin certain countries. Persons into whose possession this press release comes\nmust inform themselves about and observe any such local restrictions.\n\nAny decision to subscribe for or purchase Median Technologies shares must be\nmade solely on the basis of the publicly available information regarding\nMedian Technologies. Such information is the sole responsibility of Median\nTechnologies and has not been independently verified by TD Cowen or Stifel.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260601044395/en/\n(https://www.businesswire.com/news/home/20260601044395/en/)\n\nMEDIAN TECHNOLOGIES\n\nEmmanuelle Leygues\n\nVP, Corporate Marketing & Financial Communications\n\n+33 6 10 93 58 88\n\nemmanuelle.leygues@mediantechnologies.com \n(mailto:emmanuelle.leygues@mediantechnologies.com) \n\n\nPress – MAARC\n\nBruno Arabian\n\n+33 6 87 88 47 26\n\nbruno.arabian@maarc.fr \n(mailto:bruno.arabian@maarc.fr) \n\n\nInvestors - SEITOSEI ACTIFIN\n\nGhislaine Gasparetto\n\n+33 6 85 36 76 81\n\nghislaine.gasparetto@seitosei-actifin.com\n(mailto:ghislaine.gasparetto@seitosei-actifin.com)\n\n\nCopyright Business Wire 2026","article_body_html":"","raw_payload":{"data":{"id":"nBw9Txwkpa","title":"Median Technologies Brings Forward Subscription Period of its €50 Million Capital Increase on the Back of Strong Demand from Institutional Investors","author":"Business Wire","ticker":"ALMDT","created":"2026-06-01T15:45:00.087Z","tickers":["ALMDT"],"exchange":"Euronext Paris","article_body":"Median Technologies Brings Forward Subscription Period of its €50 Million\nCapital Increase on the Back of Strong Demand from Institutional Investors\n\n\n * The €50 million capital increase, with a subscription price of €5.00 per\nNew Share launched on May 27, 2026, is already oversubscribed\n\n * The Public Offering period, initially scheduled to close on June 3, 2026, will\nnow close early on June 2, 2026, at 5:00 p.m. (Paris time) for subscriptions\nmade over-the-counter and at 8:00 p.m. (Paris time) for online subscriptions\n\n * The Global Placement offering period closing is also brought forward to June\n2, 2026 at 5:00 p.m. (Paris time)\n\nNot to be published, distributed or disseminated, directly or indirectly, in\nthe United States of America, Australia, Canada, South Africa and Japan\n\nRegulatory News:\n\nMedian Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible,\n“Median” or the “Company”), developer of eyonis®, a suite of\nartificial intelligence (AI) powered Software as a Medical Device (SaMD) for\nearly cancer diagnosis, and a leading provider of AI-based image analyses and\ncentral imaging services for oncology clinical trials in the biopharmaceutical\nindustry, today announces the early closing of its capital increase without\nshareholders’ preferential subscription rights by way of an issue of new\nordinary shares (the “New Shares”) in the context of a public offering.\nThe New Shares are offered in (i) a public offering in France (the “Public\nOffering”), and a global placement to certain qualified investors (the\n“Global Placement”, together with the Public Offering, the “Global\nOffering”) for an amount of €40 million and (ii) an offering reserved to\nKatarina Martinson AB, Venture S.a.r.l, and Nordica Life (Bermuda) Ltd for an\namount of €10 million (the “Reserved Offering” and, together with the\nGlobal Offering, the “Offering”).\n\nOn the strength of the level of oversubscription recorded, Median Technologies\nhas decided to close the Public Offering period early on June 2, 2026, at 5:00\np.m. (Paris time) for subscriptions made over-the-counter and at 8:00 p.m.\n(Paris time) for online subscriptions. The Global Placement offering period\nwill close on June 2, 2026, at 5:00 p.m. (Paris time).\n\nFor reference, the Public Offering was initially scheduled to close on June 3,\n2026, at the same times, and the Global Placement on June 4, 2026, at 12:00\np.m. (Paris time).\n\nSettlement and delivery will also be brought forward to June 5, 2026, instead\nof the initially contemplated June 9, 2026.\n\nThe timetable of the Offering is therefore amended as follows:\n May 26, 2026  Decision of the Company’s Board of Directors and the Chief Executive Officer    \n               to launch the capital increase and set the issue price                          \n May 27, 2026  Publication of the press release announcing the launch of the Public Offering   \n               and the Global Placement – Online availability of the information document      \n               \n                                                                               \n               \nPublication by Euronext of the notice of opening of the Public Offering        \n June 2, 2026  Closing of the Global Placement offering period at 5:00 p.m. (Paris time)       \n               \n                                                                               \n               \nClosing of the Public Offering period at 5:00 p.m. (Paris time) for            \n               over-the-counter subscription orders and at 8:00 p.m. (Paris time) for          \n               subscription orders made via the Internet (if such possibility is offered by    \n               the relevant financial intermediary)                                            \n June 3, 2026  Centralization                                                                  \n               \n                                                                               \n               \nDetermination of the final terms of the capital increase (including the        \n               Reserved Offering amount)                                                       \n               \n                                                                               \n               \nSigning of the placement agreement                                             \n               \n                                                                               \n               \nPublication by the Company of the press release announcing the results of the  \n               capital increase after market close                                             \n               \n                                                                               \n               \nPublication by Euronext of the notice of results of the Offering               \n June 5, 2026  Issuance and admission to trading of the New Shares on Euronext Growth          \n               \n                                                                               \n               \nSettlement and delivery of the New Shares                                      \n\n\nAll information relating to the Offering is available on the Company’s\nwebsite at www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=1&md5=8d150a5d40d4aae7075ab26a09e4448b)\n.\n\nAbout Median Technologies: Pioneering innovative software as a medical device\nand imaging services, Median Technologies harnesses cutting-edge AI to enhance\nthe accuracy of early cancer diagnoses and treatments. Median's offerings\ninclude iCRO, which provides medical image analysis and management in oncology\ntrials, and eyonis®, an AI/ML tech-based suite of software as a medical\ndevice (SaMD). Median empowers biopharmaceutical entities and clinicians to\nadvance patient care and expedite the development of novel therapies. The\nFrench-based company, with a presence in the U.S. and China, trades on the\nEuronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is also\neligible for the French SME equity savings plan scheme (PEA-PME). For more\ninformation, visit www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=2&md5=58fe4a2cc4ddc339d03dd3235af71a65)\n.\n\nForward‑looking statements\n\nThis press release contains forward‑looking statements. These statements do\nnot constitute historical facts. These statements include projections and\nestimates and the assumptions on which they are based, statements regarding\nplans, objectives, intentions and expectations with respect to future\nfinancial results, events, operations, services, product development and their\npotential, or future performance.\n\nThese forward‑looking statements can often be identified by the use of words\nsuch as “expect”, “anticipate”, “believe”, “intend”,\n“hope”, “estimate”, “forecast,” “project,” “seek,”\n“endeavor”, “aim”, “may”, “goal”, “objective”,\n“projection”, or “plan”, as well as other similar terms. Although the\nmanagement of Median believes that these forward‑looking statements are\nreasonable, investors and shareholders are cautioned that these\nforward‑looking statements are subject to numerous risks and uncertainties,\nwhich are difficult to predict and generally beyond the control of Median\nTechnologies, and which could cause actual results and events to differ\nmaterially from those expressed, implied or forecast in the forward‑looking\ninformation and statements.\n\nThese risks and uncertainties include those described or identified in public\ndocuments, including those listed in section p), “Specific Risk Factors,”\nof the 2025 annual financial report.\n\nAll forward‑looking statements contained in this press release are based on\ninformation available to Median Technologies as of the date of this press\nrelease. Median Technologies undertakes no obligation to update the\nforward‑looking information and statements included in the press release to\nreflect any changes affecting the forecasts or the events, conditions, or\ncircumstances on which such forward-looking statements are based.\n\nAny information relating to past performance contained in this press release\nshould not be considered a guarantee of future performance. Nothing in this\npress release should be considered an investment recommendation or legal, tax,\ninvestment, or accounting advice.\n\nDisclaimer\n\nIn France, the offering of Median Technologies shares described above will be\ncarried out by way of a public offering, mainly intended for natural persons,\nand a global placement intended for qualified investors as defined in Article\n2(e) of Regulation (EU) 2017/1129 of the European Parliament and of the\nCouncil of 14 June 2017, as amended (the “Prospectus Regulation”). It will\nbe supplemented by a reserved offering to investors who have undertaken to\nsubscribe for a fixed amount at the launch of the Public Offering, if the\nsubscriptions received in the context of the Public Offering and the Global\nPlacement do not allow their subscription amount to be fully allocated, in the\ncontext of an issue reserved for a category of persons in accordance with\nArticle L.225-138 of the French Commercial Code.\n\nPursuant to the provisions of Article 211-3 of the General Regulation of the\nAutorité des marchés financiers (the “AMF”), Articles 1(4) and 3 of the\nProspectus Regulation and the applicable regulations, the offering of Median\nTechnologies shares will not give rise to the preparation of a prospectus\napproved by the AMF but only of a document containing the information set out\nin Annex IX of the Prospectus Regulation (the “Information Document”). A\ncopy of the Information Document is available on Median Technologies’\nwebsite (www.mediantechnologies.com\n(https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.mediantechnologies.com&esheet=54545468&newsitemid=20260601044395&lan=en-US&anchor=www.mediantechnologies.com&index=3&md5=ec808c16cca3cff0324960a89533a091)\n).\n\nMedian Technologies draws the attention of the public in France and of\nqualified investors in the permitted jurisdictions to section VIII “Risk\nfactors specific to the Issuer” of the Information Document.\n\nThis press release does not constitute and shall not be considered as\nconstituting a public offer, a solicitation or a sale in any jurisdiction in\nwhich such offer, solicitation or sale would be unlawful prior to registration\nor qualification under the securities laws of such jurisdiction.\n\nWith respect to the member states of the European Economic Area other than\nFrance, no action has been or will be taken to permit a public offer of the\nsecurities referred to in this press release requiring the publication of a\nprospectus in any of these member states. Accordingly, the securities may not\nbe offered and will not be offered in these member states (i) other than to\nqualified investors within the meaning of the Prospectus Regulation or (ii) in\naccordance with the other exemptions provided for in Article 1(4) of the\nProspectus Regulation or in other cases not requiring Median Technologies to\npublish a prospectus pursuant to Article 3 of the Prospectus Regulation and/or\nthe applicable regulations in such member state or in accordance with the\napplicable regulations.\n\nThis press release and the information contained herein are addressed to and\nintended only for persons who are (x) outside the United Kingdom or (y) in the\nUnited Kingdom and (i) who are “qualified investors” (as defined in\nArticle 15 of Schedule 1 to the Public Offers and Admissions to Trading\nRegulations 2024) and investment professionals within the meaning of Article\n19(5) of the Financial Services and Markets Act 2000 (Financial Promotion)\nOrder 2005, as amended (the “Financial Promotion Order”) or (ii) who fall\nwithin Article 49(2)(a) to (d) of the Financial Promotion Order (“high net\nworth companies, unincorporated associations etc.”) or (iii) are persons to\nwhom an invitation or inducement to engage in investment activity (within the\nmeaning of Article 21 of the Financial Services and Markets Act 2000) may\nlawfully be communicated or caused to be communicated (such persons referred\nto in paragraphs (y)(i), (y)(ii) and (y)(iii) together being the “Relevant\nPersons”). Any invitation, offer or agreement to subscribe for or purchase\nthe securities referred to in this press release is only available to Relevant\nPersons and may only be engaged in with Relevant Persons. This press release\nis directed only at Relevant Persons and must not be acted on or relied on by\npersons who are not Relevant Persons.\n\nThis press release may not be distributed, directly or indirectly, in the\nUnited States. This press release and the information contained herein do not\nconstitute an offer to subscribe for or purchase, or the solicitation of an\norder to purchase or subscribe for, Median Technologies shares in the United\nStates or in any other jurisdiction in which such offer or solicitation would\nbe unlawful. Securities may not be offered or sold in the United States absent\nregistration or an exemption from registration under the U.S. Securities Act\nof 1933, as amended (the “U.S. Securities Act”). Median Technologies\nshares have not been and will not be registered under the U.S. Securities Act\nand Median Technologies does not intend to conduct a public offering of Median\nTechnologies shares in the United States.\n\nThe distribution of this press release may be subject to specific regulations\nin certain countries. Persons into whose possession this press release comes\nmust inform themselves about and observe any such local restrictions.\n\nAny decision to subscribe for or purchase Median Technologies shares must be\nmade solely on the basis of the publicly available information regarding\nMedian Technologies. Such information is the sole responsibility of Median\nTechnologies and has not been independently verified by TD Cowen or Stifel.\n\n\n\nView source version on businesswire.com:\nhttps://www.businesswire.com/news/home/20260601044395/en/\n(https://www.businesswire.com/news/home/20260601044395/en/)\n\nMEDIAN TECHNOLOGIES\n\nEmmanuelle Leygues\n\nVP, Corporate Marketing & Financial Communications\n\n+33 6 10 93 58 88\n\nemmanuelle.leygues@mediantechnologies.com \n(mailto:emmanuelle.leygues@mediantechnologies.com) \n\n\nPress – MAARC\n\nBruno Arabian\n\n+33 6 87 88 47 26\n\nbruno.arabian@maarc.fr \n(mailto:bruno.arabian@maarc.fr) \n\n\nInvestors - SEITOSEI ACTIFIN\n\nGhislaine Gasparetto\n\n+33 6 85 36 76 81\n\nghislaine.gasparetto@seitosei-actifin.com\n(mailto:ghislaine.gasparetto@seitosei-actifin.com)\n\n\nCopyright Business Wire 2026"},"type":"article","timestamp":"2026-06-01T15:45:00.219514283Z","server_sent_at_ms":1780328700219},"received_at":"2026-06-01T15:45:00.321Z","source_url":"https://www.businesswire.com/news/home/20260601044395/en/"},"analysis":{"id":"40525","press_release_id":"51093","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":["Capital increase results in share dilution","Offering is not available in the United States"],"eventType":"offering","narrative":"Median Technologies is raising €50 million through a capital increase priced at €5.00 per share, split between a €40 million public/global placement and a €10 million reserved offering.\n\nStrong institutional demand has forced the company to bring forward the subscription closing date from June 3 to June 2, 2026, indicating the offering is oversubscribed.\n\nThe new shares will be issued and admitted to trading on Euronext Growth on June 5, 2026, resulting in immediate dilution for existing shareholders.","sentiment":"neutral","agentHooks":{"shouldPost":true,"suggestedAngle":"Median Technologies oversubscribes €50M raise, closing early on June 2; watch for dilution impact on June 5."},"keyFigures":{"dealValueUsd":"€50 million","offeringPrice":"€5.00","sharesOffered":0,"customDimensions":{"public_offering_amount":"€40 million","reserved_offering_amount":"€10 million"}},"quotedText":"The €50 million capital increase, with a subscription price of €5.00 per New Share launched on May 27, 2026, is already oversubscribed","namedEntities":{"people":[{"name":"Emmanuelle Leygues","role":"VP, Corporate Marketing & Financial Communications"},{"name":"Bruno Arabian","role":"Press Contact (MAARC)"},{"name":"Ghislaine Gasparetto","role":"Investor Contact (SEITOSEI ACTIFIN)"}],"products":["eyonis","iCRO"],"companies":[{"name":"Median Technologies","ticker":"ALMDT","relationship":"filer"},{"name":"Katarina Martinson AB","relationship":"reserved offering subscriber"},{"name":"Venture S.a.r.l","relationship":"reserved offering subscriber"},{"name":"Nordica Life (Bermuda) Ltd","relationship":"reserved offering subscriber"},{"name":"TD Cowen","relationship":"underwriter"},{"name":"Stifel","relationship":"underwriter"}],"dollarAmounts":[{"amount":"€50 million","context":"total capital increase amount"},{"amount":"€5.00","context":"subscription price per New Share"},{"amount":"€40 million","context":"Public Offering and Global Placement amount"},{"amount":"€10 million","context":"Reserved Offering amount"}]},"materialImpact":{"score":3,"reasoning":"The company is raising €50 million via a capital increase, which is a material dilutive event. The early closing due to oversubscription is a positive signal of demand, but the net effect is dilution. Score 3 reflects the materiality of the raise without extreme distress or massive discount."},"tickerRelevance":{"others":[],"primary":"ALMDT"},"globalImportance":25,"audienceRelevance":15,"eventTypeSecondary":["dilution"],"importanceComponents":{"tickerTier":"small-cap","eventGravity":"dilutive offering","sectorWeight":"moderate","householdBrandBoost":0,"marketCapAdjustment":"low","retailFavoriteBoost":0}},"event_type":"offering","event_type_secondary":["dilution"],"sentiment":"neutral","material_impact_score":3,"narrative":"Median Technologies is raising €50 million through a capital increase priced at €5.00 per share, split between a €40 million public/global placement and a €10 million reserved offering.\n\nStrong institutional demand has forced the company to bring forward the subscription closing date from June 3 to June 2, 2026, indicating the offering is oversubscribed.\n\nThe new shares will be issued and admitted to trading on Euronext Growth on June 5, 2026, resulting in immediate dilution for existing shareholders.","key_figures":{"dealValueUsd":"€50 million","offeringPrice":"€5.00","sharesOffered":0,"customDimensions":{"public_offering_amount":"€40 million","reserved_offering_amount":"€10 million"}},"named_entities":{"people":[{"name":"Emmanuelle Leygues","role":"VP, Corporate Marketing & Financial Communications"},{"name":"Bruno Arabian","role":"Press Contact (MAARC)"},{"name":"Ghislaine Gasparetto","role":"Investor Contact (SEITOSEI ACTIFIN)"}],"products":["eyonis","iCRO"],"companies":[{"name":"Median Technologies","ticker":"ALMDT","relationship":"filer"},{"name":"Katarina Martinson AB","relationship":"reserved offering subscriber"},{"name":"Venture S.a.r.l","relationship":"reserved offering subscriber"},{"name":"Nordica Life (Bermuda) Ltd","relationship":"reserved offering subscriber"},{"name":"TD Cowen","relationship":"underwriter"},{"name":"Stifel","relationship":"underwriter"}],"dollarAmounts":[{"amount":"€50 million","context":"total capital increase amount"},{"amount":"€5.00","context":"subscription price per New Share"},{"amount":"€40 million","context":"Public Offering and Global Placement amount"},{"amount":"€10 million","context":"Reserved Offering amount"}]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-06-01T15:46:07.595Z","global_importance":25,"audience_relevance":15,"importance_components":{"tickerTier":"small-cap","eventGravity":"dilutive offering","sectorWeight":"moderate","householdBrandBoost":0,"marketCapAdjustment":"low","retailFavoriteBoost":0}},"durationMs":67261,"modelName":"george-droid-qwen-72b"}}